Problem patents in innovator pharma

In this recent European Biopharmaceutical Review article, Lee and Vandana analyse freedom to operate from the innovator perspective in the pharmaceutical and biotechnology areas.

Here’s a link to the pdf – Think IP Strategy EBR Summer 2010

Please do let us know what you think.